Xinhua News Agency, Shanghai, December 31 (Reporter Guo Jingdan) The reporter learned from the Shanghai Municipal People’s Congress that the “Provisions of Shanghai Pudong New Area on Promoting the Construction of Zhangjiang Biomedical Industry Innovation Highland” has been voted at the 38th meeting of the Standing Committee of the 15th Shanghai Municipal People’s Congress The adoption will help Pudong accelerate the construction of an innovative highland for the biomedical industry with global influence.
At the same time, this local legislation further focuses on the health needs of the people and the problem of "emergency and worry", stipulating that the Shanghai Municipal People's Government can authorize qualified medical institutions in Pudong New Area to import a small amount of clinically needed drugs and medical devices within the scope of national authorization.
The regulations passed this time are the sixth Pudong New Area regulations.
In June 2021, the 29th meeting of the Standing Committee of the 13th National People’s Congress passed relevant decisions by voting to authorize the Shanghai Municipal People’s Congress and its Standing Committee to comply with the requirements of Pudong’s reform and innovation practice and follow the constitutional provisions and basic laws and administrative rules. Formulate Pudong New Area regulations and implement them in Pudong New Area.
This provision consists of 34 articles, which will further improve the policy support system, enhance the capacity of scientific and technological innovation sources, and improve the overall efficiency of reforms. It will be implemented on January 1, 2022.
The regulations clarify the responsibilities of the Shanghai and Pudong New Area People’s Governments and their relevant departments, and Pudong New Area’s relevant streets, towns, and park management agencies. Carry out scientific argumentation on planning, key layout and other matters, and put forward opinions and suggestions.
According to the regulations passed this time, for in vitro diagnostic reagents that have no products of the same type on the market in China, qualified medical institutions in Pudong New Area can develop them on their own according to clinical needs and use them in their units under the guidance of practicing physicians.
In terms of cross-border retail, in accordance with relevant national authorizations, in relevant regions, pilots will promote eligible Pudong New Area drug and medical device trading platforms to carry out cross-border e-commerce retail imports of certain drugs and medical devices.
At the same time, Shanghai and Pudong New Area will further increase support for the development of the biomedical industry.
For example, for key projects that conform to the development orientation of the biomedical industry, optimize the use of land, floor area ratio, building height, etc.; in terms of government procurement, implement the first purchase and order system for innovative biomedical products that meet the requirements.